Pelthos Therapeutics Inc.
PTHSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PTHS. That does not mean none is planned.
Get an email about PTHS's next catalysts
Track Pelthos Therapeutics (PTHS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
PTHS Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-2.83 | FQ end Sep/2026 | Call: tbd
How PTHS's past catalysts played out
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Pelthos Therapeutics Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Pelthos Therapeutics Inc. (PTHS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PTHS biotech catalysts?→
Add PTHS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Pelthos Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.